Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Foeldvari

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Arthritis and Rheumatism|March 2, 2010
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
The Journal of Rheumatology|March 3, 2016
Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic ArthritisTamas Constantin, Ivan Foeldvari, Jelena Vojinovic, et al.
Rheumatology (Oxford, England)|August 25, 2022
Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide studyKarin Melsens, Maurizio Cutolo, Dieneke Schonenberg-Meinema, et al.
The Lancet. Rheumatology|January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statementsAnna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
Annals of the Rheumatic Diseases|August 9, 2019
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort studyGabriele Valentini, Dörte Huscher, Antonella Riccardi, et al.
Annals of the Rheumatic Diseases|May 17, 2017
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trialHermine I Brunner, Nicolino Ruperto, Nikolay Tzaribachev, et al.
Arthritis Care & Research|November 3, 2020
Underdetection of Interstitial Lung Disease in Juvenile Systemic SclerosisIvan Foeldvari, Jens Klotsche, Bernd Hinrichs, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2024
Classification Criteria for Axial Disease in Youth With Juvenile SpondyloarthritisPamela F Weiss, Timothy G Brandon, Amita Aggarwal, et al.
Annals of the Rheumatic Diseases|December 13, 2016
Update of EULAR recommendations for the treatment of systemic sclerosisOtylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 27, 2018
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label StudyHermine I Brunner, Nikolay Tzaribachev, Gabriel Vega-Cornejo, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Arthritis and Rheumatism|March 2, 2010
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
The Journal of Rheumatology|March 3, 2016
Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic ArthritisTamas Constantin, Ivan Foeldvari, Jelena Vojinovic, et al.
Rheumatology (Oxford, England)|August 25, 2022
Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide studyKarin Melsens, Maurizio Cutolo, Dieneke Schonenberg-Meinema, et al.
The Lancet. Rheumatology|January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statementsAnna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
Annals of the Rheumatic Diseases|August 9, 2019
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort studyGabriele Valentini, Dörte Huscher, Antonella Riccardi, et al.
Annals of the Rheumatic Diseases|May 17, 2017
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trialHermine I Brunner, Nicolino Ruperto, Nikolay Tzaribachev, et al.
Arthritis Care & Research|November 3, 2020
Underdetection of Interstitial Lung Disease in Juvenile Systemic SclerosisIvan Foeldvari, Jens Klotsche, Bernd Hinrichs, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2024
Classification Criteria for Axial Disease in Youth With Juvenile SpondyloarthritisPamela F Weiss, Timothy G Brandon, Amita Aggarwal, et al.
Annals of the Rheumatic Diseases|December 13, 2016
Update of EULAR recommendations for the treatment of systemic sclerosisOtylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 27, 2018
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label StudyHermine I Brunner, Nikolay Tzaribachev, Gabriel Vega-Cornejo, et al.
Pageof 18